-+ 0.00%
-+ 0.00%
-+ 0.00%

IVONESCIMAB IN COMBINATION WITH CHEMOTHERAPY APPROVED IN CHINA BY NMPA FOR FIRST-LINE TREATMENT OF PATIENTS WITH SQUAMOUS NON-SMALL CELL LUNG CANCER

Reuters·08/12/2026 13:22:00

Please log in to view news